2016-2

Yılmaz G, et al: D-index
Turk J Hematol 2016;33:102-106
Interpretation: Gülden Yılmaz, Belgin Coşkun, Atilla Elhan, Alpay
Azap, Hamdi Akan; Literature Search: Gülden Yılmaz, Belgin
Coşkun, Atilla Elhan, Alpay Azap, Hamdi Akan; Writing: Gülden
Yılmaz, Belgin Coşkun, Atilla Elhan, Alpay Azap, Hamdi Akan.
Conflict of Interest: The authors of this paper have no conflicts
of interest, including specific financial interests, relationships,
and/or affiliations relevant to the subject matter or materials
included.
References
1. Kriengkauykiat J, Ito J, Dadwai S. Epidemiology and treatment approaches
in management of invasive fungal infections. Clin Epidemiol 2011;3:175-
191.
2. Michallet M, Ito JI. Approaches to the management of invasive
fungal infections in hematologic malignancy and hematopoietic cell
transplantation. J Clin Oncol 2009;27:3398-3409.
3. Nucci M, Anaissie EJ, Queiroz-Telles F, Martins CA, Trabasso P, Solza C,
Mangini C, Simões BP, Colombo AL, Vaz J, Levy CE, Costa S, Moreira VA,
Oliveira JS, Paraguay N, Duboc G, Voltarelli JC, Maiolino A, Pasquini R, Souza
CA. Outcome predictors of 84 patients with hematologic malignancies and
Fusarium infection. Cancer 2003;98:315-319.
4. De Pauw BE, Meunier F. The challenge of invasive fungal infection.
Chemotherapy 1999;45:1-14.
5. Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C,
Chevrier S, Meunier C, Lebert C, Aupée M, Caulet-Maugendre S, Faucheux M,
Lelong B, Leray E, Guiguen C, Gangneux JP. Comparison of epidemiological,
clinical, and biological features of invasive aspergillosis in neutropenic and
nonneutropenic patients: a 6-year survey. Clin Infect Dis 2006;43:577-584.
6. Nucci M. Use of antifungal drugs in hematology. Rev Bras Hematol Hemoter
2012;34:383-391.
7. Offidani M, Corvatta L, Olivieri A, Rupoli S, Frayfer J, Mele A, Manso E,
Montanari M, Centurioni R, Leoni P. Infectious complications after
autologous peripheral blood progenitor cell transplantation followed by
G-CSF. Bone Marrow Transplant 1999;24:1079-1087.
8. Portugal RD, Garnica M, Nucci M. Index to predict invasive mold infection
in high-risk neutropenic patients based on the area over the neutrophil
curve. J Clin Oncol 2009;27:3849-3854.
9. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T,
Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson
TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler
CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A,
Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T,
Bennett JE; European Organization for Research and Treatment of Cancer/
Invasive Fungal Infections Cooperative Group; National Institute of Allergy
and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus
Group. Revised definitions of invasive fungal disease from the European
Organization for Research and Treatment of Cancer/Invasive Fungal
Infections Cooperative Group and the National Institute of Allergy and
Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
Clin Infect Dis 2008;46:1813-1821.
10. Usansky JI, Desai A, Tang-Liu D. PK Functions for Microsoft Excel. Irvine, CA,
USA, Department of Pharmacokinetics and Drug Metabolism of Allergan
Inc. (available at www. boomer.org/pkin/xcel/pkf/pkf.doc).
11. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in
allogeneic stem cell transplant recipients: changes in epidemiology and risk
factors. Blood 2002;100:4358-4366.
12. Li L, Wang J, Zhang W, Yang J, Chen L, Lv S. Risk factors for invasive mold
infections following allogeneic hematopoietic stem cell transplantation: a
single center study of 190 recipients. Scand J Infect Dis 2012;44:100-107.
13. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome
of mould infections in hematopoietic stem cell transplant recipients. Clin
Infect Dis 2002;34:909-917.
14. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis
following hematopoietic cell transplantation: outcomes and prognostic
factors associated with mortality. Clin Infect Dis 2007;44:531-540.
15. Maertens J, Theunissen K, Verhoef G, Verschakelen J, Logrou K, Verbeken
E, Wilmer A, Verhaegen J, Boogaerts M, Van Eldere J. Galactomannan and
computed tomography based preemptive antifungal therapy in neutropenic
patients at high risk for invasive fungal infection: a prospective feasibility
study. Clin Infect Dis 2005;41:1242-1250.
16. Cordonnier C, Pautas C, Maury S, Vekhoff A, Farhat H, Suarez F, Dhédin N,
Isnard F, Ades L, Kuhnowski F, Foulet F, Kuentz M, Maison P, Bretagne S,
Schwarzinger M. Empirical versus preemptive antifungal therapy for high
risk, febrile, neutropenic patients: a randomized, controlled trial. Clin Infect
Dis 2009;48:1042-1051.
17. Hebart H, Klingspor L, Klingebiel T, Loeffler J, Tollemar J, Ljungman P, Wandt
H, Schaefer-Eckart K, Dornbusch HJ, Meisner C, Engel C, Stenger N, Mayer T,
Ringden O, Einsele H. A prospective randomized controlled trial comparing
PCR based and empirical treatment with liposomal amphotericin B in
patients after allo-SCT. Bone Marrow Transplant 2009;43:553-561.
18. Maschmeyer G, Heinz WJ, Hertenstein B, Horst HA, Requadt C, Wagner
T, Cornely OA, Löffler J, Ruhnke M; IDEA study investigators. Immediate
versus deferred empirical antifungal (IDEA) therapy in high-risk patients
with febrile neutropenia: a randomized, double-blind, placebo-controlled,
multicenter study. Eur J Clin Microbiol Infect Dis 2013;32:679-689.
19. Cesaro S, Pagano L, Caira M, Carraro F, Luciani M, Russo D, Colombini A,
Morello W, Viale P, Rossi G, Tridello G, Pegoraro A, Nosari A, Aversa F; Hemae-chart
Group. A prospective, multicenter survey on antifungal therapy in
neutropenic pediatric haematology patients. Mycoses 2013;56:21-25.
20. Kimura S, Oshima K, Sato K, Sato M, Terasako K, Hideki N, Kikuchi M, Okuda
S, Yamazaki R, Tanaka Y, Tanihara A, Nishida J, Kanda Y. Retrospective
evaluation of the area over the neutrophil curve index to predict early
infection in hematopoietic stem cell transplantation recipients. Biol Blood
Marrow Transplant 2010;16:1355-1361.
21. Wald A, Leisenring W, van Burik J, Bowden RA. Epidemiology of Aspergillus
infections in a large cohort of patients undergoing bone marrow
transplantation. J Infect Dis 1997;175:1459-1466.
22. Baddley J, Stroud T, Salzman D, Pappas P. Invasive mold infections in
allogeneic bone marrow transplant recipients. Clin Infect Dis 2001;32:1319-
1324.
23. Akan H. Antifungal treatment in stem cell transplantation centers in
Turkey. In: 23rd European Congress of Clinical Microbiology and Infectious
Diseases, Berlin, Germany, 27-30 April 2013.
106